Watch our free on-demand webinar sponsored by Immunovant, Inc., to hear from clinical experts Mark Lupo, MD, founder and medical director of the Thyroid & Endocrine Center of Florida, and Giuseppe Barbesino, MD, of Massachusetts General Hospital, for a moderated discussion about the treatment landscape in Graves’ disease, which has remained largely unchanged for the last 70 years.
Key topics include:
- The pathophysiology of Graves’ disease as an autoimmune disease
- Characteristics of patients who may be sub-optimally treated
- Challenges with existing treatment options
- The potential for new treatment approaches in development to address patient needs
Learning Objectives
Upon completion of the webinar, participants should be able to:
- Review the immunologic pathways that contribute to the manifestations of Graves’ disease
- Describe the benefits and limitations of current therapeutic options for the treatment of Graves’ disease
- Assess patient-specific considerations that may inform the future approach to treating Graves’ disease
Target Audience
This webinar is intended for medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents, and fellows in training.
Watch Webinar
Thank you to our webinar sponsor:
